Rx Rebating Bills In House, Senate Come Into Alignment As Passage Likely Punted to 2024

 
• By Sarah Karlin-Smith

Legislation to delink PBM payments from drug prices advances in House Energy and Commerce health subcommittee, putting a key pharma priority closer to the finish line. Whether patients will see any benefit remains a worry.

runners close to finish line
PBM reform getting closer to finish line in both House and Senate • Source: Shutterstock

More from Legislation

More from Pink Sheet